Literature DB >> 28478533

Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

Beatriz Fiuza Gomes1,2, Rebeca Souza3, Thiago Valadão3, Newton Kara-Junior4, Haroldo Vieira Moraes5, Marcony R Santhiago4.   

Abstract

PURPOSE: To evaluate the relationship between glaucoma diagnosis and the nailfold capillaroscopy pattern in patients with systemic sclerosis.
METHODS: An observational study in a cohort of patients with SSc was conducted. Patients with at least one nailfold videocapillaroscopy and one ophthalmology examination at the same year were included. Data collected were: age, sex; type of systemic sclerosis according to the degree of skin impairment, self-reported ethnicity, disease duration, current use and dosage of systemic corticosteroid, current use and dosage of bosentan®, intraocular pressure, central corneal thickness, diagnosis of glaucoma and capillaroscopy pattern.
RESULTS: Thirty-one patients with systemic sclerosis were enrolled, 23% had glaucoma. There was no statistically significant association between glaucoma diagnosis and the capillaroscopic pattern (p = 0.86). There was also no significant difference (p = 0.66) regarding intraocular pressure between patients with mild (13.9 ± 3.8 mmHg) and severe capillaroscopic pattern (14.4 ± 2.8 mmHg). The odds ratio of glaucoma for severe capillaroscopic pattern compared to mild was 1.6 (95% confidence interval: 0.3-9.5).
CONCLUSION: Up to 23% of patients with SSc have glaucoma. The high prevalence of glaucoma in SSc suggests a possible systemic vascular disturbance as the cause. However, there seems to be no significant association between the capillaroscopy pattern and glaucoma in systemic sclerosis. Further research is required to improve the understanding of glaucoma in the context of systemic sclerosis.

Entities:  

Keywords:  Glaucoma; Intraocular pressure; Nailfold capillaroscopy; Pathogenesis; Systemic sclerosis

Mesh:

Year:  2017        PMID: 28478533     DOI: 10.1007/s10792-017-0454-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  31 in total

Review 1.  Scleroderma - new aspects in pathogenesis and treatment.

Authors:  Alexandra Balbir-Gurman; Yolanda Braun-Moscovici
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-02       Impact factor: 4.098

2.  Anterior segment parameters and eyelids in systemic sclerosis.

Authors:  Sevinc Sahin Atik; Feray Koc; Sirin Akin Sari; Nazife Sefi Yurdakul; Mustafa Ozmen; Servet Akar
Journal:  Int Ophthalmol       Date:  2015-12-23       Impact factor: 2.031

Review 3.  New therapeutic strategies in the management of systemic sclerosis.

Authors:  Yannick Allanore; Jèrôme Avouac; Julien Wipff; André Kahan
Journal:  Expert Opin Pharmacother       Date:  2007-04       Impact factor: 3.889

Review 4.  Biomarkers in systemic sclerosis: Their potential to predict clinical courses.

Authors:  Minoru Hasegawa
Journal:  J Dermatol       Date:  2016-01       Impact factor: 4.005

Review 5.  Ocular manifestations of scleroderma.

Authors:  Rajen Tailor; Abha Gupta; Ariane Herrick; Jeffrey Kwartz
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

Review 6.  Endothelin: is it a contributor to glaucoma pathophysiology?

Authors:  Thomas Yorio; Raghu Krishnamoorthy; Ganesh Prasanna
Journal:  J Glaucoma       Date:  2002-06       Impact factor: 2.503

Review 7.  Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.

Authors:  Otavio Cabral-Marques; Gabriela Riemekasten
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 8.  Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review.

Authors:  Michele Iudici; Marlies C van der Goes; Gabriele Valentini; Johannes W J Bijlsma
Journal:  Clin Exp Rheumatol       Date:  2013-07-23       Impact factor: 4.473

9.  Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.

Authors:  Hemma Resch; Katharina Karl; Günther Weigert; Michael Wolzt; Anton Hommer; Leopold Schmetterer; Gerhard Garhöfer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-21       Impact factor: 4.799

10.  Prevalence of ocular manifestations in systemic sclerosis patients.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Piotr Jurowski
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

View more
  2 in total

1.  Structural features of eyelid connective tissue in patients with primary open-angle glaucoma.

Authors:  L A Svetikova; E N Iomdina; N Y Ignatyeva; A N Serik; S F Migal; N A Nazarova
Journal:  Int Ophthalmol       Date:  2018-10-12       Impact factor: 2.031

2.  Structural abnormalities associated with glaucoma using swept-source optical coherence tomography in patients with systemic sclerosis.

Authors:  Cecilia Victoria Agapito Tito; Juliana Silvatti; Izabela N F de Almeida; Elise V Taniguchi; Tiago S Prata; Augusto Paranhos; Cristiane Kayser
Journal:  Int Ophthalmol       Date:  2021-11-25       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.